Thai giant eyes £2.5bn move for Birds Eye

  • Print
  • Share
  • Comments (1)
  • Save

Birds Eye could be the next British brand to head east after becoming the subject of a £2.5bn takeover bid.

Thailand’s Charoen Pokphand Foods – which has offices in Worcestershire and supplies own-label food for Tesco from a factory in Newmarket – launched the bid on Friday. Rival offers are thought to have been made by private equity giants Blackstone and BC Partners.

The move comes after Birds Eye’s current private equity owner, Permira, put the business up for sale in March.

Earlier this month, Weetabix was sold to Bright Food of China in a deal valuing the cereal giant at £1.2bn.

Readers' comments (1)

  • Rather sad that another iconic plateful of my childhood may no longer be British owned.

    Unsuitable or offensive? Report this comment

Have your say

These comments have not been moderated.

You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment.

Any comment that violates these terms may be removed in its entirety as we do not edit comments.

If you wish to complain about a comment please use the “report this comment” facility or email groceremails@wrbm.com

Mandatory
Mandatory
Mandatory
Mandatory
  • Print
  • Share
  • Comments (1)
  • Save
Sign in

Newsletter Sign-up

Free

I wish to receive the following newsletters:

For Members

Become a Gold Member to receive these newsletters:

Become a Finance Member to receive these newsletters:

Become a member of The Grocer

DIRECTORY

The+Grocer+Directory

CLICK HERE to search for the products, services and companies you need in the definitive guide to the UK food and drink industry.

FOLLOW THE GROCER

The Grocer's commentators and opinion makers